5 Most Undervalued Pharma Stocks To Buy According To Analysts

Page 5 of 5

1. Organon & Co. (NYSE:OGN)

Share Price Upside: 74%

Organon & Co. (NYSE:OGN) is a diversified healthcare company that sells drugs and medical devices. Investment bank Goldman Sachs is one of the most bullish among those that cover Organon & Co. (NYSE:OGN)’s shares, as it believes that the company’s women health products can do well in their market.

During Q2 2023, 31 out of the 910 hedge funds profiled by Insider Monkey had invested in Organon & Co. (NYSE:OGN). Alec Litowitz and Ross Laser’s Magnetar Capital is the largest investor among these since it owns $36 million worth of shares.

Follow Organon & Co.

Disclosure: None. You can also take a look at 16 Best Growth Stocks To Buy According To Hedge Funds and 12 Best Clean Laundry Detergent Brands.

Follow Insider Monkey on Twitter

Page 5 of 5